China BioPharma Ltd. Manufacturing Partner Receives SFDA Approval To Deliver Flu Vaccine For The First Batch Release Of The 2006-2007 Season

Published: Aug 31, 2006

HANGZHOU, China--(BUSINESS WIRE)--Aug. 31, 2006--China Biopharma Inc. (OTCBB: TEDG) today announced that Zhejiang Tianyuan Biopharmaceutical, the Company's manufacturing joint venture partner, received approval from the Chinese State Food and Drug Administration (SFDA) to deliver its flu vaccine product for the first batch release of the 2006-2007 influenza season. The Company commenced shipping of the first lots of its flu vaccine product last week to local Centers for Disease Control & Prevention (China CDCs) and hospitals.

Back to news